Revista Española de Quimioterapia,
Год журнала:
2023,
Номер
36(6), С. 612 - 620
Опубликована: Сен. 24, 2023
To
assess
the
frequency
of
bacterial
coinfection
upon
ICU
admission
in
SARS-CoV-2
pneumonia
patients,
its
microbiology,
and
impact
on
prognosis.The
secondary
objective
was
to
identify
risk
factors
for
admission.Retrospective
study,
including
patients
with
admitted
ICU.We
defined
by
respiratory
symptoms,
radiological
data,
positive
clinically
significant
microbiological
results
samples
obtained
first
48
h
and/or
a
determination
procalcitonin
≥
0.5
ng/mL
h.We
evaluated
demographic
variables,
comorbidities,
infection
severity
scores,
treatments
received,
need
support
outcomes
(ICU
hospital
mortality).A
total
182
were
analyzed,
62
(34.1%)
coinfection.The
most
frequent
microbiology
S.
pneumoniae
M.
pneumoniae.
96.1%
received
antibiotic
therapy
admission,
98.9%
corticosteroids,
27.5%
tocilizumab,
7.7%
remdesivir.85.7%
required
invasive
mechanical
ventilation.The
SOFA
score
(OR:
1.315,
95%
CI1.116-1.548)
delay
0.899,
CI
0.831-0.972)
related
coinfection.
Bacterial
increases
death
(OR
2.283;
1.011.5.151;
p=0.047).Bacterial
is
common
COVID
death.
It
not
possible
certainty,
at
time
which
do
benefit
from
treatment.
Journal of Clinical Medicine,
Год журнала:
2022,
Номер
11(23), С. 7207 - 7207
Опубликована: Дек. 4, 2022
The
issue
of
bacterial
infections
in
COVID-19
patients
has
received
increasing
attention
among
scientists.
Antibiotics
were
widely
prescribed
during
the
early
phase
pandemic.
We
performed
a
literature
review
to
assess
reasons,
evidence
and
practices
on
use
antibiotics
in-
outpatients.
Published
articles
providing
data
identified
through
computerized
searches
MEDLINE
SCOPUS
databases.
Searching
database,
following
search
terms
adopted:
((antibiotic)
AND
(COVID-19)).
used:
((antibiotic
treatment)
risk
bias
included
studies
was
not
assessed.
Both
quantitative
qualitative
information
summarized
by
means
textual
descriptions.
Five-hundred-ninety-three
identified,
published
from
January
2020
30
October
2022.
Thirty-six
this
systematic
review.
Of
36
studies,
32
inpatients
4
antibiotic
Apart
review,
main
recommendations
treatment
5
guidelines
for
clinical
management
also
separate
paragraph.
should
be
unless
there
is
strong
suspicion
coinfection
or
superinfection.
The Lancet Microbe,
Год журнала:
2024,
Номер
5(3), С. e272 - e281
Опубликована: Фев. 2, 2024
Viral
respiratory
tract
infections
are
frequently
complicated
by
secondary
bacterial
infections.
This
study
aimed
to
use
machine
learning
predict
the
risk
of
superinfection
in
SARS-CoV-2-positive
individuals.
Mathematical Modelling and Numerical Simulation with Applications,
Год журнала:
2022,
Номер
unknown
Опубликована: Дек. 1, 2022
We
propose
a
new
epidemic
model
to
study
the
coinfection
dynamics
of
COVID-19
and
bacterial
pneumonia,
which
is
first
in
literature
used
describe
mathematically
interaction
these
two
diseases
while
considering
infection
ways
for
pneumonia:
community-acquired
hospital-acquired
transmission.
show
that
existence
local
stability
equilibria
depend
on
three
different
parameters,
are
interpreted
as
basic
reproduction
numbers
COVID-19,
population
hospital.
Numerical
simulations
performed
complement
our
theoretical
analysis,
we
both
can
persist
if
number
greater
than
one.
Journal of Personalized Medicine,
Год журнала:
2022,
Номер
12(6), С. 877 - 877
Опубликована: Май 26, 2022
Since
the
beginning
of
COVID-19
pandemic,
empiric
antibiotics
(ATBs)
have
been
prescribed
on
a
large
scale
in
both
in-
and
outpatients.
We
aimed
to
assess
impact
antibiotic
treatment
outcomes
hospitalised
patients
with
moderate
severe
coronavirus
disease
2019
(COVID-19).We
conducted
prospective
multicentre
cohort
study
six
clinical
hospitals,
between
January
2021
May
2021.We
included
553
patients,
whom
58%
(311/553)
were
antibiotics,
while
bacteriological
tests
performed
57%
(178/311)
them.
Death
was
outcome
48
patients-39
from
ATBs
group
9
non-ATBs
group.
The
who
received
during
hospitalisation
had
higher
mortality
(RR
=
3.37,
CI
95%:
1.7-6.8),
this
association
stronger
subgroup
without
reasons
for
antimicrobial
6.1,
1.9-19.1),
therapy
not
statistically
significant
(OR
2.33,
0.76-7.17).
After
adjusting
confounders,
receiving
remained
associated
only
criteria
prescription
10.3,
2-52).In
our
study,
did
decrease
risk
death
mild
COVID-19,
but
it.
Antibiotics,
Год журнала:
2023,
Номер
12(1), С. 144 - 144
Опубликована: Янв. 11, 2023
1.Literature
data
on
bacterial
infections
and
their
impact
the
mortality
rates
of
COVID-19
patients
from
Romania
are
scarce,
while
worldwide
reports
contrasting.
2.We
conducted
a
unicentric
retrospective
observational
study
that
included
280
with
SARS-CoV-2
infection,
whom
we
performed
various
microbiological
determinations.
Based
administration
or
not
antibiotic
treatment,
divided
into
two
groups.
First,
sought
to
investigate
predictors
infections,
causative
microbial
strains,
prescribed
treatment.
Secondly,
aimed
identify
risk
factors
associated
in-hospital
death
evaluate
biomarkers'
performance
for
predicting
short-term
mortality.
3.Bacterial
co-infections
secondary
were
confirmed
in
23
(8.2%)
patients.
Acinetobacter
baumannii
was
pathogen
responsible
most
infections.
Almost
three
quarters
(72.8%)
received
empiric
therapy.
Multivariate
logistic
regression
has
shown
leukocytosis
intensive
care
unit
admission
as
C-reactive
protein,
together
length
hospital
stay,
predictors.
The
ROC
curves
revealed
an
acceptable
erythrocyte
sedimentation
rate
(AUC:
0.781),
protein
0.797),
but
poor
fibrinogen
0.664)
fatal
events.
4.This
highlighted
somewhat
paradoxical
association
low
high
A
thorough
assessment
addition
acknowledgment
predictors,
is
crucial
identifying
high-risk
patients,
thus
allowing
timely
therapeutic
intervention,
direct
improving
patients'
prognosis.
Antibiotics,
Год журнала:
2024,
Номер
13(6), С. 545 - 545
Опубликована: Июнь 12, 2024
The
issue
of
bacterial
infections
in
COVID-19
patients
has
received
increasing
attention.
Scant
data
are
available
on
the
impact
superinfection
and
antibiotic
administration
outcome
hospitalized
patients.
We
conducted
a
literature
review
from
1
January
2022
to
31
March
2024
assess
current
burden
infection
evidence
for
use
Published
articles
providing
were
identified
through
computerized
searches
with
search
terms
[(antibiotic)
AND
(COVID-19)]
or
[(antibiotic
treatment)
(COVID-19)].
PubMed
SCOPUS
databases
searched
2024.
No
attempt
was
made
obtain
information
about
unpublished
studies.
English
language
restriction
applied.
quality
included
studies
evaluated
by
tool
recommended
Joanna
Briggs
Institute.
Both
quantitative
qualitative
summarized
means
textual
descriptions.
Five
hundred
fifty-one
identified,
twenty-nine
this
systematic
review.
Of
29
studies,
18
prevalence
patients;
4
reported
efficacy
early
COVID-19;
sepsis
biomarkers
improve
use;
3
antimicrobial
stewardship
programs
predictive
models
among
COVID-19-hospitalized
high
35%
medium
62%.
High
rates
hospital-acquired
patients,
ranging
between
7.5
37.7%.
A
resistance
rate
developing
infections,
in-hospital
mortality
rate.
evaluating
multi-faceted
interventions
decreasing
consumption
lower
mortality.
Frontiers in Public Health,
Год журнала:
2023,
Номер
11
Опубликована: Авг. 29, 2023
Similar
to
influenza,
coinfections
and
superinfections
are
common
might
result
in
poor
prognosis.
Our
study
aimed
compare
the
characteristics
risks
of
severe
COVID-19
influenza
virus
pneumonia.The
data
patients
with
admitted
intensive
care
unit
(ICU)
were
retrospectively
analyzed.
The
primary
outcome
was
describe
prevalence
pathogenic
distribution
coinfections/ICU-acquired
population.
secondary
evaluate
independent
risk
factors
for
at
ICU
admission.
Multivariate
analysis
survivors
non-survivors
performed
investigate
whether
an
prognostic
factor.In
(n
=
123)
145)
cohorts,
incidence
33.3%/43.9
35.2%/52.4%,
respectively.
most
bacteria
identified
coinfection
cases
Enterococcus
faecium,
Pseudomonas
aeruginosa,
Acinetobacter
baumannii
(COVID-19
cohort)
A.
baumannii,
P.
Klebsiella
pneumoniae
(influenza
cohort).
A
significant
higher
proportion
events
sustained
by
Aspergillus
spp.
[(22/123,
17.9%
COVID-19)
(18/145,
12.4%
influenza)].
group
had
more
ICU-acquired
Corynebacterium
striatum
K.
pneumoniae.
three
prevalent
pathogens
superinfections.
Patients
APACHE
II
≥18,
CD8+
T
cells
≤90/μL,
50
<
age
≤
70
years
susceptible
coinfections;
while
those
CRP
≥120
mg/L,
IL-8
≥
20
pg./mL,
blood
glucose
≥10
mmol/L,
hypertension,
smoking
a
group.
superinfection,
corticosteroid
administration
treatment
before
admission,
SOFA
score
7
COVID-19.Patients
or
high
represent
agents
different
from
general
ward.
These
high-risk
should
be
closely
monitored
empirically
treated
effective
antibiotics
according
pathogen.
Antimicrobial Resistance and Infection Control,
Год журнала:
2024,
Номер
13(1)
Опубликована: Апрель 14, 2024
Abstract
Background
COVID-19
and
bacterial/fungal
coinfections
have
posed
significant
challenges
to
human
health.
However,
there
is
a
lack
of
good
tools
for
predicting
coinfection
risk
aid
clinical
work.
Objective
We
aimed
investigate
the
factors
among
patients
develop
machine
learning
models
estimate
coinfection.
Methods
In
this
retrospective
cohort
study,
we
enrolled
adult
inpatients
confirmed
with
in
tertiary
hospital
between
January
1
July
31,
2023,
China
collected
baseline
information
at
admission.
All
data
were
randomly
divided
into
training
set
testing
ratio
7:3.
developed
generalized
linear
random
forest
assessed
performance
set.
Decision
curve
analysis
was
performed
evaluate
applicability.
Results
A
total
1244
included
62
healthcare-associated
infections,
while
534
22
infections.
found
that
comorbidities
(diabetes,
neurological
disease)
greater
than
those
without
(OR
=
2.78,
95%CI
1.61–4.86;
OR
1.93,
1.11–3.35).
An
indwelling
central
venous
catheter
or
urinary
also
associated
an
increased
2.53,
1.39–4.64;
2.28,
1.24–4.27)
coinfections.
Patients
PCT
>
0.5
ng/ml
2.03
times
(95%CI
1.41–3.82)
more
likely
be
infected.
Interestingly,
IL-6
concentration
<
10
pg/ml
1.69,
0.97–2.94).
low
creatinine
levels
had
decreased
coinfections(OR
0.40,
0.22–0.71).
The
demonstrated
favorable
receiver
operating
characteristic
curves
(ROC
0.87,
0.80–0.94;
ROC
0.88,
0.82–0.93)
high
accuracy,
sensitivity
specificity
0.86vs0.75,
0.82vs0.86,
0.87vs0.74,
respectively.
corresponding
calibration
evaluation
P
statistics
0.883
0.769.
Conclusions
Our
achieved
strong
predictive
ability
may
effective
decision-support
identifying
guiding
antibiotic
administration.
cytokines,
such
as
IL-6,
affect
status
Biomedical Journal of Scientific & Technical Research,
Год журнала:
2024,
Номер
55(3)
Опубликована: Март 5, 2024
The
World
Health
Organization
recorded
antimicrobial
multidrug
resistance
as
one
of
the
biggest
health
risks
in
2019.
inappropriate
use
antibiotics
results
their
consequent
ineffectiveness
treatment
bacterial
infections,
hindering
therapeutic
alternatives
and
increasing
risk
poor
prognosis.
In
late
2019,
a
single-stranded
RNA
zoonotic
virus,
SARS-CoV-2,
was
identified
caused
Coronavirus
Disease-19
pandemic.
prophylactically
for
secondary
infections
measures
taken
emergency
scenario.
Antimicrobial Stewardship & Healthcare Epidemiology,
Год журнала:
2024,
Номер
4(1)
Опубликована: Янв. 1, 2024
The
primary
objectives
of
this
study
were
to
assess
the
usefulness
C-reactive
protein
(CRP)
and
procalcitonin
(PCT)
in
diagnosis
bacterial
co-infections
coronavirus
disease
2019
(COVID-19)
if
their
incorporation
antimicrobial
stewardship
(AMS)
programs
is
safe
useful,
stratified
by
severity
as
level
care,
intensive
care
unit
(ICU)
or
non-ICU.
Our
secondary
identify
cut-off
values
for
antibiotic
decision-making
reported
results
from
low-
middle-income
countries
(LMICs).